(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

NANOREADY

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

NANOREADY

ST13

US500000079402228

Classe

5, 10, 40, 42

Pedido

79402228

Registro

7772914

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

27

Atualização mais recente

05/06/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 10, 40, 42

Data de depósito

07/06/2024

Data de registro

29/04/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

29/04/2025

Última transação

05/06/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

98

Localização do titular

KR

Examinador

BLAKESLEE, RICHARD A

Unidade examinadora

N50

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

S. C. (pessoa física)
Samyang Holdings Corporation

Representantes

Richard Y. Kim Snell & Wilmer L.L.P.

Classificação técnica

Classes Nice

Classe 5Classe 10Classe 40Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparations for health carein particular for the prevention and treatment of canceroncological disordersautoimmune diseasesinflammatory diseasesfibrotic diseases and infectious diseases and for use in genetic therapy for the prevention and treatment of genetic disorders; medicine casesportablefilledin the nature of first-aid kits; vaccines; food supplements; vitamin and mineral dietary supplements; veterinary substances and preparations for the prevention and treatment of canceroncological disordersautoimmune diseasesinflammatory diseasesfibrotic diseases and infectious diseases and for use in genetic therapy for the prevention and treatment of genetic disorders; medicinal preparations for the mouth in the form of dropscapsulestabletscompressed tablets for the treatment of canceroncological disordersautoimmune diseasesinflammatory diseasesfibrotic diseasesinfectious diseasesgenetic disorders; ointments for pharmaceutical purposes for the treatment of paininflammation and skin disorders; cachets for pharmaceutical purposes for the treatment of canceroncological disordersautoimmune diseasesinflammatory diseasesfibrotic diseasesinfectious diseasesgenetic disorders; pharmaceutical preparations being adrenalparathyroidpituitarypancreassalivary gland hormone preparations for human use; ferments for pharmaceutical purposes; pre-moistened medicated tissues; pharmaceutical preparationselixirs for the treatment of canceroncological disordersautoimmune diseasesinflammatory diseasesfibrotic diseasesinfectious diseasesgenetic disorders; drugs for medical purposespharmaceutical preparations for the treatment of canceroncological disordersautoimmune diseasesinflammatory diseasesfibrotic diseasesinfectious diseasesgenetic disorders; pharmaceutical drugspharmaceutical preparations for the treatment of canceroncological disordersautoimmune diseasesinflammatory diseasesfibrotic diseasesinfectious diseasesgenetic disorders; human vaccine preparations; medicines for human purposespharmaceutical preparations for the treatment of canceroncological disordersautoimmune diseasesinflammatory diseasesfibrotic diseasesinfectious diseasesgenetic disorders; pharmaceutical preparations for the treatment of cancer; nutraceutical preparations for therapeutic or medical purposes for the treatment of canceroncological disordersautoimmune diseasesinflammatory diseasesfibrotic diseasesinfectious diseasesgenetic disorders; antibiotics; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules sold empty and tablets that provide controlled release of the active ingredients that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of coatings for tablets that facilitate the delivery of nutritional supplements

Classe 10

Surgical gloves; surgical apparatus and instruments for veterinary use; veterinary apparatuselectrocardiographsX-ray apparatusultrasound apparatus and medical imaging apparatus for veterinary purposes; surgical instruments for use in general surgery; surgical sutures; surgical apparatus and instruments for medicaldental or veterinary use; medical instruments for use in general surgery; medical apparatusnamely medical radiation apparatusmedical X-ray apparatusmedical imaging apparatus; medical instrumentsnamely medical hearing instruments; sanitary masks for medical use; cold-hot massage apparatus for medical use; suture materials for medical use; surgical apparatus and instruments for medical use; thread for medical use; protective face masks for medical use; gloves for medical purposes; medical apparatusmedical apparatus for detecting cancermedical imaging apparatusultrasonic medical diagnostic apparatus; apparatus for drug administrationinfusion and injection devices for administering drugs; syringes for injection of medical substances; orthopedic articlesorthopedic beltsorthopedic solesorthopedic footwearorthopedic bandagesorthopedic bandages for joints and orthopaedic hosieryorthopedic apparatus and instruments for diagnostic and therapeutic use; dental instrumentsnamely root canal therapy instruments used to shave the inside of a root canaldental root files used in root canal therapy proceduresreusable and recyclable prophy anglesprophy anglesdisposable prophy anglesoral irrigatorshemostats that clamp blood vessels to diminish or halt blood flowcrown and bridge removers

Classe 40

Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; preservation of pharmaceuticals; custom manufacture of pharmaceuticals; destruction of medical waste; custom manufacture of medical devices for others; custom assembling of electronic components for medical devices; recycling of medical waste; processing of pharmaceuticals being custom manufacture of pharmaceuticals; manufacture of custom dental bridges for others; custom manufacture of dental prosthesis and dentures; processing and treatment of chemical reagents

Classe 42

Research and development of vaccines and medicines; biological information checkgenetic testing for medical research purposes; pharmaceutical research services; inspection of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; services for assessing the efficiency of pharmaceuticalsproduct quality testing services; technological and scientific remote monitoring services relating to medical diagnostic devicesremote monitoring of medical diagnostic systems for quality control purposes; medical research laboratories; providing computer software technical support servicestroubleshooting of computer software problems in the field of medical diagnostics; providing technological support services regarding medical diagnostic instrumentstroubleshooting of computer software problems; scientific research relating to medicines; analysis and evaluation of medical product development; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; providing information on the testinginspection and scientific research of medical products; consultancy in the field of testinginspectionscientific research of medical products; blood testing for scientific medical research purposes; engineering services in the field of medical technology

Publicações

Histórico de despachos e eventos da marca no USPTO.

27 publicações encontradas

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/06/2026

CHLD

CHANGE OF OWNER RECEIVED FROM IB

19/02/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

29/01/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

14/01/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

14/01/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/12/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

23/11/2025

FIMP

FINAL DISPOSITION PROCESSED

23/11/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

30/07/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

29/04/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

29/04/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/03/2025

PUBO

PUBLISHED FOR OPPOSITION

11/03/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/03/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

18/02/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

13/02/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

13/02/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

13/02/2025

RFNT

REFUSAL PROCESSED BY IB

01/02/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/01/2025

RFRR

REFUSAL PROCESSED BY MPU

10/01/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

19/12/2024

CNRT

NON-FINAL ACTION WRITTEN

18/12/2024

DOCK

ASSIGNED TO EXAMINER

17/12/2024

MAFR

APPLICATION FILING RECEIPT MAILED

21/08/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

21/08/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

15/08/2024

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace NANOREADY ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.